Thesis icon

Thesis

Investigating the role of the endocannabinoid system and gut-microbiome in psychotic and severe mental illness: a focus on negative symptoms

Abstract:

Negative symptoms, such as anhedonia and amotivation, represent unmet therapeutic needs and key determinants of functional loss in severe mental illness. Albeit traditionally considered a unique feature of schizophrenia, anhedonia and amotivation manifest outside the psychotic spectrum, where they are equally debilitating and difficult to treat. A number of clinical trials using newly developed compounds or re-repurposing existing drugs have tried to treat negative symptoms without su...

Expand abstract

Actions

Access Document

Files:

Authors

More by this author
Division:
MSD
Department:
Psychiatry
Role:
Author

Contributors

Role:
Supervisor
ORCID:
0000-0002-4972-8786
Role:
Supervisor


More from this funder
Funder identifier:
http://dx.doi.org/10.13039/501100000265
Programme:
Oxford - MRC DTP –St John’s College – Clarendon Studentship


DOI:
Type of award:
DPhil
Level of award:
Doctoral
Awarding institution:
University of Oxford


Language:
English
Keywords:
Subjects:
Pubs id:
2043435
Local pid:
pubs:2043435
Deposit date:
2021-05-14
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP